GLP-1 medications can alter bowel movements, with constipation and diarrhea being the most common side effects. These drugs slow digestion to help control appetite, which can lead to changes in stool ...
Researchers also noted a reduced risk of self-harm among people taking GLP-1 medications Angelique Brenes is a writer-reporter at PEOPLE. She joined PEOPLE in 2026. Her work has previously appeared on ...
There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...
More than 10 percent of U.S. adults take GLP-1 drugs. But not all of them are taking full doses. Around one in seven users has “microdosed” injections, a recent survey by the health tracking app ...
People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...
One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems. However, if people stop taking the medication, those heart ...
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also ...
“RESIST SAYING, ‘this will be no panacea’. When you find something that is a panacea, that will indeed be news.” This wise advice once appeared in The Economist’s Style Guide, and the first part is ...
Dieticians are warning that GLP-1 use can lead to extreme malnutrition, manifesting in diseases like scurvy, amid findings that the vast majority of studies fail to consider patients’ eating habits.
The miracle of rapid weight loss has always come with fine print. Until recently, it read mostly like a list of digestive complaints — stomachaches, constipation — generally unpleasant but tolerable ...
This revelation could cut addiction-related deaths by 50 percent. As scientists unravel the link between GLP-1 medications and addiction, it may hold clues for the development a drug that can treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results